Glyn B. Steventon

2.5k total citations
72 papers, 2.0k citations indexed

About

Glyn B. Steventon is a scholar working on Molecular Biology, Biochemistry and Pharmacology. According to data from OpenAlex, Glyn B. Steventon has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Biochemistry and 17 papers in Pharmacology. Recurrent topics in Glyn B. Steventon's work include Sulfur Compounds in Biology (19 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). Glyn B. Steventon is often cited by papers focused on Sulfur Compounds in Biology (19 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). Glyn B. Steventon collaborates with scholars based in United Kingdom, United States and Thailand. Glyn B. Steventon's co-authors include R. H. Waring, M. T. E. Heafield, Adrian C. Williams, Peter J. Houghton, Adrian Williams, Melanie-Jayne Howes, Peter J. Hylands, Peter J. Houghton, Rui Fang and Stephen C. Mitchell and has published in prestigious journals such as The Lancet, Development and Neurology.

In The Last Decade

Glyn B. Steventon

71 papers receiving 1.9k citations

Peers

Glyn B. Steventon
Lidia Włodek Poland
Venkataraman Amarnath United States
Xia Li China
Luana Heimfarth Brazil
Małgorzata Iciek Poland
Lucia Marcocci Italy
Jonathan A. Doorn United States
Jeevan K. Prasain United States
Yoshichika Kawai Japan
Ryohei Kimura Japan
Lidia Włodek Poland
Glyn B. Steventon
Citations per year, relative to Glyn B. Steventon Glyn B. Steventon (= 1×) peers Lidia Włodek

Countries citing papers authored by Glyn B. Steventon

Since Specialization
Citations

This map shows the geographic impact of Glyn B. Steventon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glyn B. Steventon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glyn B. Steventon more than expected).

Fields of papers citing papers by Glyn B. Steventon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glyn B. Steventon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glyn B. Steventon. The network helps show where Glyn B. Steventon may publish in the future.

Co-authorship network of co-authors of Glyn B. Steventon

This figure shows the co-authorship network connecting the top 25 collaborators of Glyn B. Steventon. A scholar is included among the top collaborators of Glyn B. Steventon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glyn B. Steventon. Glyn B. Steventon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mitchell, Stephen C., et al.. (2019). Drug S-oxidation and phenylalanine hydroxylase: a biomarker for neurodegenerative susceptibility in Parkinson’s disease and amyotrophic lateral sclerosis. Drug Metabolism and Personalized Therapy. 34(2). 4 indexed citations
3.
Steventon, Glyn B. & Stephen C. Mitchell. (2018). Phenylalanine hydroxylase: A biomarker of disease susceptibility in Parkinson’s disease and Amyotrophic lateral sclerosis. Medical Hypotheses. 118. 29–33. 7 indexed citations
4.
Lucas, Christopher D., et al.. (2015). Phenylalanine monooxygenase and the sulfur oxygenation of S-carboxymethyl-l-cysteine in mice. Xenobiotica. 46(4). 379–384. 5 indexed citations
5.
6.
Mitchell, Stephen C., Glyn B. Steventon, & R. H. Waring. (2009). Metabolic Fate of Phenothiazine in the Marmoset (Callithrix jacchus). Drug metabolism and drug interactions. 24(2-4). 137–152. 1 indexed citations
7.
Forbes, Ben, et al.. (2008). Phenylalanine 4-monooxygenase and the S-Oxidation of S-Carboxymethyl-L-cysteine by Human Cytosolic Fractions. Drug metabolism and drug interactions. 23(3-4). 261–282. 13 indexed citations
8.
Paoletta, Silvia, Glyn B. Steventon, Dirk Wildeboer, et al.. (2008). Screening of herbal constituents for aromatase inhibitory activity. Bioorganic & Medicinal Chemistry. 16(18). 8466–8470. 37 indexed citations
9.
10.
Mitchell, S. C., et al.. (2005). PHENYLALANINE 4-MONOOXYGENASE AND THE S-OXIDATION OF S-CARBOXYMETHYL-L-CYSTEINE IN HepG2 CELLS. Drug metabolism and drug interactions. 21(1). 1–18. 14 indexed citations
11.
Steventon, Glyn B., et al.. (2005). Induction of Cysteine Dioxygenase Activity by Oral Administration of Cysteine Analogues to the Rat: Implications for Drug Efficacy and Safety. Drug metabolism and drug interactions. 21(2). 75–86. 1 indexed citations
12.
Steventon, Glyn B., et al.. (2004). Use of High-Pressure Liquid Chromatography with Fluorescence Detection for the in vitro Assay of S-Carboxymethyl-L-Cysteine S-Oxygenase. Chromatographia. 59(3-4). 237–242. 8 indexed citations
13.
Steventon, Glyn B., et al.. (2004). Phenylalanine hydroxylase and the S-oxidation of L-methionine. Journal of Inherited Metabolic Disease. 27. 31–31. 1 indexed citations
14.
Steventon, Glyn B., S. Sturman, R. H. Waring, & Adrian Williams. (2001). A Review of Xenobiotic Metabolism Enzymes in Parkinson's Disease and Motor Neuron Disease. Drug metabolism and drug interactions. 18(2). 79–98. 16 indexed citations
15.
Waring, R. H., et al.. (1998). Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. Journal of the Neurological Sciences. 156(1). 102–106. 80 indexed citations
16.
Harland, C. C., Glyn B. Steventon, & J.R. Marsden. (1995). Thalidomide-induced neuropathy and genetic differences in drug metabolism. European Journal of Clinical Pharmacology. 49(1-2). 1–6. 39 indexed citations
17.
Peters, Leila Priscila, et al.. (1994). D-Penicillamine metabolism in neurodegenerative diseases: Anin vivo/in vitrosulphydryl methylation study. Xenobiotica. 24(10). 1013–1020. 9 indexed citations
18.
Steventon, Glyn B., et al.. (1990). Metabolism of low-dose paracetamol in patients with chronic neurological disease. Xenobiotica. 20(1). 117–122. 28 indexed citations
19.
Heafield, M. T. E., et al.. (1990). Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neuroscience Letters. 110(1-2). 216–220. 387 indexed citations
20.
Steventon, Glyn B., et al.. (1988). XENOBIOTIC METABOLISM IN MOTORNEURON DISEASE. The Lancet. 332(8612). 644–647. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lidia Włodek Breakdown of academic impact, for papers by Venkataraman Amarnath Breakdown of academic impact, for papers by Xia Li Breakdown of academic impact, for papers by Luana Heimfarth Breakdown of academic impact, for papers by Małgorzata Iciek Breakdown of academic impact, for papers by Lucia Marcocci Breakdown of academic impact, for papers by Jonathan A. Doorn Breakdown of academic impact, for papers by Jeevan K. Prasain Breakdown of academic impact, for papers by Yoshichika Kawai Breakdown of academic impact, for papers by Ryohei Kimura
Rankless by CCL
2026